THE INVISIBLE MASK

Serial Number 79302177
Registration 6557525
700

Registration Progress

Application Filed
Sep 28, 2020
Under Examination
Approved for Publication
Apr 6, 2021
Published for Opposition
Apr 6, 2021
Registered
Nov 16, 2021

Trademark Image

THE INVISIBLE MASK

Basic Information

Serial Number
79302177
Registration Number
6557525
Filing Date
September 28, 2020
Registration Date
November 16, 2021
Published for Opposition
April 6, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 16, 2021
Registration
Registered
Classes
005

Rights Holder

JNTL Consumer Health I (Switzerland) GmbH

27
Address
Gubelstrasse 34
CH-6300 Zug
CH

Ownership History

Nasaleze Patents Limited

Original Applicant
99
GB

Nasaleze Patents Limited

Owner at Publication
99
GB

Nasaleze Patents Limited

Original Registrant
99
GB

JNTL Consumer Health I (Switzerland) GmbH

New Owner After Registration #1
27
CH

Legal Representation

Attorney
Matthew Pater

USPTO Deadlines

Next Deadline
741 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-11-16)
Due Date
November 16, 2027
Grace Period Ends
May 16, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

33 events
Date Code Type Description Documents
Sep 19, 2024 CHLD M CHANGE OF OWNER RECEIVED FROM IB Loading...
Sep 9, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 9, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Sep 9, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Sep 9, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 9, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 9, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 30, 2022 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
May 6, 2022 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
May 6, 2022 FIMP P FINAL DISPOSITION PROCESSED Loading...
Feb 16, 2022 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Nov 16, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 7, 2021 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
May 7, 2021 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Apr 19, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Apr 6, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 6, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 31, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Mar 31, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Mar 17, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 15, 2021 RFNT P REFUSAL PROCESSED BY IB Loading...
Mar 2, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 1, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 26, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 26, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 24, 2021 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Feb 23, 2021 RFRR P REFUSAL PROCESSED BY MPU Loading...
Feb 12, 2021 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Feb 11, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 10, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 19, 2021 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jan 15, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 14, 2021 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Biological preparations for medical purposes for the treatment of hay fever, asthma, eczema, allergies, viral disease and aerial pollution-related disease; bronchodilatory preparations; cellulose ethers for pharmaceutical purposes; cellulose esters for pharmaceutical purposes; chemical preparations for medical purposes, namely, for the treatment of hay fever, asthma, eczema, allergies, viral disease and aerial pollution-related disease; chemical preparations for pharmaceutical purposes all for use in the treatment, relief and prevention of hay fever, asthma, eczema, allergies, viral disease and aerial pollution-related disease

Classification

International Classes
005